Some error occured while loading the Quick View. Please close the Quick View and try reloading the page.
The book "Viral Diseases: History and New Developments in Diagnostics and Therapeutics" provides a comprehensive exploration of viral infections, their history, diagnostic advancements, and therapeutic developments. It aims to bridge the gap between past outbreaks and modern scientific progress by offering an in-depth analysis of viral biology, infection mechanisms, and the impact of human activities on viral emergence. The book's key focus is the integration of next-generation diagnostic methods that offer enhanced sensitivity and rapid results. It also discusses the regulatory frameworks for translating laboratory discoveries into clinically approved treatments and vaccines. By addressing both the scientific and practical aspects of virology, the book provides valuable insights into the future of viral disease management.
Key Features:
-
Presents the most recent diagnostic tools and techniques used for the identification of viral diseases.
-
Covers current therapeutic approaches to deal effectively with viral diseases.
-
Explores bioinformatics approaches to vaccine development.
-
Relates current scientific details to the COVID-19 virus pandemic and how it has changed standard approaches toward disease management.
-
Covers specifics and future prospects related to theragnostic for viral disease control.
Arvind K. Singh Chandel is a Research Assistant Professor in the School of Chemical System Engineering at the University of Tokyo. He is proficient in polymers, hydrogels, nanoparticles, adhesives, sponges, wound care, and antimicrobial agents for biomedical applications. With 36 peer-reviewed publications, including eight as the first author and an H-index of 22, he holds eight patents, has contributed to 20 book chapters, and has published four magazine articles. He received the prestigious JSPS postdoctoral fellowship, the DBT M.K. Bhan Young Researcher Fellowship, and the Marie Skłodowska-Curie Fellowship.
Bhakti Tanna is the Director at Bosker Medico Services, leads the Medical Writing and Pharmacovigilance departments. With a Ph.D. and vast expertise in molecular biology, in vitro studies, analytical techniques, gene analysis, and pharmaceuticals, she brings a strong blend of academic and industry experience. Her passion for scientific excellence drives innovation in research, regulatory compliance, and medical communications.
Amisha Parmar is a PhD student at the University of Veterinary Medicine, Vienna, is a pharmacologist with eight years of experience in industry and academia. She specializes in in vivo and in vitro preclinical research, focusing on both basic and translational neuroscience in the therapeutic areas of neurodegenerative diseases and neuropathic pain.
Gopal Patel is a Professor at Lakshmi Narain College of Pharmacy, Bhopal, Madhya Pradesh, India. He has almost 12 years of Teaching and Research Experience in the field of Pharmaceutical Biotechnology, Enzymology, Fermentation and Nano-biotechnology. He has published around 25 SCI publications and 3 book Chapters.
Neeraj S. Thakur is a Researcher at the University of Oklahoma Health Sciences (OUHS), Oklahoma City, USA. He has 12 years of experience in pharmaceutical technology, theranostics and infectious diseases. He has contributed to several articles, book chapters, patents and conference presentations internationally.
Preface
Acknowledgements
Editor biographies
List of contributors
1 The effect of human interference on ecology and infectious diseases
2 History of viral disease
3 Contagiousness and threats of most prevalent viral diseases worldwide
4 Drug development process: clinical trials and regulations
5 Molecular diagnostic techniques utilized in viral diseases
6 Variant identification techniques targting viral infections
7 Next generation sequencing: disease detection, research, and treatment
8 Nanotechnology in diagnostics
9 Antiviral agents: mechanisms of action and therapeutic insights
10 Ethnopharmacological approaches for COVID-19 therapy
11 Plasma therapy
12 RNAi in viral control diagnostics
13 MicroRNA (miRNA) therapeutic modalities
14 Novel targets: host proteins, nucleic acid, and antibodies
15 Pathophysiology of coronavirus disease 2019 (COVID-19)
16 Advances in COVID-19 diagnosis and treatment interventions
17 Theranostics: a hope for viral diseases